E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/24/2006 in the Prospect News Biotech Daily.

IP Group funds Retroscreen

By Elaine Rigoli

Tampa, Fla., Aug. 24 - IP Group plc said it has invested £1 million for 51,133 ordinary shares in Retroscreen Virology Ltd., a spin-out company from Queen Mary, University of London. Following the investment, IP Group will have a 25% stake in Retroscreen.

Retroscreen's turnover for the year ended July 31, 2005 was £1.1 million and profits after taxes were £0.1 million. Unaudited turnover and profits after taxes for the year were £2.4 million and £0.5 million, respectively.

The investment by IP Group in Retroscreen represents the first investment as part of the partnership with Queen Mary, University of London announced in July. Bruce Campbell, chief scientific officer of IP Group, will become a non-executive director of Retroscreen.

IP Group, based in London, is an intellectual property commercialization company.

Retroscreen is a contract virology research company based in London.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.